MedTrace Logo

Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study

NCT04214964 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2021-10-07

No results posted yet for this study

Summary

Gynecological tumors are serious threats to women's health. Ovarian Cancer (OC), uterine and cervical malignancies (c-uc) are common gynecological malignancies, which are featured by high morbidity and mortality, limited late-stage efficacy, easy recurrence and drug resistance.

Real World Study (RWS) refers to the study based on a large sample size (covering representative subjects), according to the actual condition, carry out evaluation for a long time, and pay attention to the outcome of treatment, meaningful to further evaluate external validity and safety of the intervention measures.

this study is devoted to the provide the real world evidence for the clinical treatment of gynecological malignant tumors in China.

Conditions

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Qinglei Gao, MD, PhD · Tongji Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-11
Primary Completion
2022-10-01
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04214964 on ClinicalTrials.gov